TRIM9 anticorps (C-Term)
Aperçu rapide pour TRIM9 anticorps (C-Term) (ABIN2388398)
Antigène
Voir toutes TRIM9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 655-684, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- TRIM9, CT (TRIM9, KIAA0282, RNF91, E3 ubiquitin-protein ligase TRIM9, RING finger protein 91, Tripartite motif-containing protein 9)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- TRIM9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 655-684 amino acids from the C-terminal region of human TRIM9.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- TRIM9 (Tripartite Motif Containing 9 (TRIM9))
-
Autre désignation
- TRIM9
-
NCBI Accession
- NP_443210, NP_055978
-
UniProt
- Q9C026
-
Pathways
- Synaptic Vesicle Exocytosis
Antigène
-